Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,640,900
+$1,386,683 QoQ
Shares Held
6,461
+521.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,512
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Mar 31, 2025CallValue
$3,316,800
CallShares
20,000
PutValue
$3,316,800
PutShares
20,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $100,420,553 across 10 Drug Manufacturers - General names. JNJ ranks #7 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
240,327 | $48,495,411 | |
| 2 | ABBV |
AbbVie Inc.
|
104,287 | $26,242,780 | |
| 3 | GSK |
GSK plc
|
199,265 | $10,445,471 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
57,030 | $7,205,170 | |
| 5 | NVS |
Novartis AG
|
16,468 | $2,580,864 | |
| 6 | MRK |
Merck & Co., Inc.
|
15,528 | $1,995,348 | |
| 7 | JNJ |
Johnson & Johnson
This page
|
6,461 | $1,640,900 | |
| 8 | SNY |
Sanofi
|
15,897 | $678,166 |
All Filings in JNJ
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,640,900 | 6,461 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $254,217 | 1,040 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $70,781,674 | 381,737 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,003,720 | 6,571 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $66,583,764 | 401,494 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $3,316,800 | 20,000 | Put | Sole | 2025-05-15 | |
| 2025-03-31 | $3,316,800 | 20,000 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $43,115,415 | 298,129 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $29,494,920 | 182,000 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $61,899,303 | 381,953 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,308,000 | 50,000 | Put | Sole | 2024-08-14 | |
| 2024-06-30 | $7,308,000 | 50,000 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $717,645 | 4,910 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,436,839 | 9,083 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $787,148 | 5,022 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $23,362,500 | 150,000 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $7,787,500 | 50,000 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $8,388,227 | 53,857 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $19,138,746 | 115,628 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $24,107,150 | 155,530 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $19,350,947 | 109,544 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $21,375,002 | 130,846 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,930,872 | 27,778 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $17,468,143 | 98,562 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,198,153 | 18,695 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,244,413 | 51,049 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $955,492 | 5,800 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $16,587,188 | 100,926 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,020,422 | 31,900 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,833,213 | 25,747 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $2,961,667 | 21,060 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,026,092 | 7,825 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||